Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies Journal Article


Authors: Veeriah, S.; Taylor, B. S.; Meng, S.; Fang, F.; Yilmaz, E.; Vivanco, I.; Janakiraman, M.; Schultz, N.; Hanrahan, A. J.; Pao, W.; Ladanyi, M.; Sander, C.; Heguy, A.; Holland, E. C.; Paty, P. B.; Mischel, P. S.; Liau, L.; Cloughesy, T. F.; Mellinghoff, I. K.; Solit, D. B.; Chan, T. A.
Article Title: Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies
Abstract: Mutation of the gene PARK2, which encodes an E3 ubiquitin ligase, is the most common cause of early-onset Parkinson's disease. In a search for multisite tumor suppressors, we identified PARK2 as a frequently targeted gene on chromosome 6q25.2-q27 in cancer. Here we describe inactivating somatic mutations and frequent intragenic deletions of PARK2 in human malignancies. The PARK2 mutations in cancer occur in the same domains, and sometimes at the same residues, as the germline mutations causing familial Parkinson's disease. Cancer-specific mutations abrogate the growth-suppressive effects of the PARK2 protein. PARK2 mutations in cancer decrease PARK2's E3 ligase activity, compromising its ability to ubiquitinate cyclin E and resulting in mitotic instability. These data strongly point to PARK2 as a tumor suppressor on 6q25.2-q27. Thus, PARK2, a gene that causes neuronal dysfunction when mutated in the germline, may instead contribute to oncogenesis when altered in non-neuronal somatic cells. © 2010 Nature America, Inc. All rights reserved.
Keywords: controlled study; unclassified drug; somatic mutation; gene deletion; mutation; neoplasm; animals; mice; lung neoplasms; protein; colonic neoplasms; genetic association; genotype; gene frequency; genetic variation; mice, scid; cell line, tumor; carcinogenesis; tumor suppressor gene; blotting, western; ubiquitination; glioblastoma; neoplasms, experimental; transplantation, heterologous; base sequence; mitosis rate; models, molecular; protein structure, tertiary; dna mutational analysis; gene dosage; parkinson disease; ubiquitin protein ligase e3; comparative genomic hybridization; ubiquitin-protein ligases; chromosome 6q; cyclin e; park2 protein
Journal Title: Nature Genetics
Volume: 42
Issue: 1
ISSN: 1061-4036
Publisher: Nature Publishing Group  
Date Published: 2010-01-01
Start Page: 77
End Page: 82
Language: English
DOI: 10.1038/ng.491
PUBMED: 19946270
PROVIDER: scopus
PMCID: PMC4002225
DOI/URL:
Notes: --- - "Cited By (since 1996): 12" - "Export Date: 20 April 2011" - "CODEN: NGENE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Adriana Heguy
    88 Heguy
  2. Timothy Chan
    317 Chan
  3. Philip B Paty
    501 Paty
  4. David Solit
    781 Solit
  5. Emrullah Yilmaz
    2 Yilmaz
  6. William Pao
    141 Pao
  7. Eric Holland
    225 Holland
  8. Marc Ladanyi
    1332 Ladanyi
  9. Fang Fang
    6 Fang
  10. Igor Vivanco
    12 Vivanco
  11. Chris Sander
    210 Sander
  12. Barry Stephen Taylor
    238 Taylor
  13. Nikolaus D Schultz
    491 Schultz
  14. Shasha Meng
    4 Meng